Analysis of affordability differences for rare diseases in China: a comparison across disease types and regions
Abstract Background China has implemented policies to make rare diseases more affordable. While previous studies evaluated overall affordability, few have examined affordability differences across regions and disease types. Given the vastness of China and varying medical policies across cities, this...
Main Authors: | Ye Chen, Xinyang Chen, Yi Deng, Jinxi Ding |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | International Journal for Equity in Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12939-024-02137-z |
Similar Items
-
Analysing the impact of the Medicaid expansion under the affordable care act on the healthcare expenditures for individuals with chronic conditions
by: Ang, Jia Yi, et al.
Published: (2024) -
Evaluating the national system for rare diseases in China from the point of drug access: progress and challenges
by: Luyao Qiao, et al.
Published: (2022-09-01) -
Advances in Rare Diseases in China (2020—2021)
by: HE Shan, et al.
Published: (2022-01-01) -
Research of Accessibility of Rare Disease Drugs Based on the China's First List of Rare Diseases
by: LIU Qingyang, et al.
Published: (2023-11-01) -
Gender Differences in Caring for Children with Genetic or Rare Diseases: A Mixed-Methods Study
by: Shao-Yin Chu, et al.
Published: (2022-04-01)